Real-time enrollment status for this sarcoma clinical trial
Current Status
Suspended
Checked: March 2, 2026 at 2:01 PM UTC
| NCT Number | NCT04890093 |
| Recruiting Status | Suspended |
| Condition | Sarcoma |
| Phase | Clinical Trial |
| Target Enrollment | 64 participants |
| Active Locations | 2 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | February 5, 2026 (3 weeks ago) |
As of March 2, 2026: Clinical trial NCT04890093 is currently suspended participants. This clinical trial study for sarcoma is not currently accepting new participants at 2 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT04890093 is currently suspended. The study may resume recruiting in the future.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04890093 was last updated 3 weeks ago (February 5, 2026). HelloStudys verifies this status automatically.